Life Science Compliance Update

December 16, 2013

CME Grant Disclosures for 2012 to 3rd Quarter of 2013

We have compiled a chart of companies that have disclosed their educational grant payments for 2012-2013. Some companies have disclosure information for several years. Now that grants are subject to Sunshine Act reporting requirements for teaching hospitals, it is likely more companies will begin to post such payments to teaching hospitals. We will add additional information as it becomes available.

Company

2013 

2012 

2011 

2010

2009

Abbott

 

Q1

Q1

Q1

Q1

   

Q2

Q2

Q2

Q2

   

Q3

Q3

Q3

Q3

     

Q4

Q4

Q4

           

Allergan

Q1 & Q2

Q1 & Q2

Q1 & Q2

   
   

Q3 & Q4

Q3 & Q4

Q3

 
           

Amgen

Q1

Q1

Q1

Q1

Q1

 

Q2

Q2

Q2

Q2

Q2

 

Q3

Q3

Q3

Q3

Q3

   

Q4

Q4

Q4

Q4

           

Astellas Pharma US, Inc.

 

Q1

Q1

Q1

 
 

Q2

Q2

Q2

Q2

 
 

Q3

Q3

Q3

Q3

 
   

Q4

Q4

Q4

Q4

           

Astra Zeneca

Q1 & Q2

Q1& Q2

Q1 & Q2

Q1 & Q2

Q1 & Q2

   

Q3 & Q4

Q3 &Q4

Q3 &Q4

Q3 &Q4

           

Bristol-Myers Squibb

Q1

Q1

     
 

Q2

Q2

     
 

Q3

Q3

     
   

Q4

     
           

Forest Labs

Q1

2012 Full Year

2011 Full Year

2010 Full Year

 
 

Q2

       
 

Q3

       
           

Genentech

 

2012 Full Year

2011 Full Year

2010 Full Year

 
           

Biosense Webster

Q1 & Q2

Q3 & Q4 (starting page 3)

     

Janssen Biotech

Q1-Q3

 

 

   

Cordis

Q1 & Q2

Q3 & Q4 (starting page 3)

     
           

Depuy Mitek, Inc.

Q1 & Q2

Q3 & Q4 (starting page 3)

     
           

Depuy Orthopaedics, Inc.

Q1 & Q2

Q3 & Q4 (starting page 3)

     
           

Depuy Spine, Inc.

Q1 & Q2

Q3 & Q4 (starting page 3)

     
           

Codman and Shurtleff, Inc.

Q1 & Q2

Q3 & Q4 (starting page 3)

     
           

Ethicon

Q1 & Q2

Q3 & Q4 (starting page 3)

     
           

Janssen Pharmaceuticals, Inc.

Q1-Q3

       
           

Janessen Biotech, Inc.

Q1-Q3

 

Q1 2011

   
           

Janssen Therapeutics

Q1-Q3

       
           

Therakos

 

2012:
Q1 & Q2

2011:
Q3 & Q4 (starts page 3)

   
           

Eli Lilly

Q1-Q3

2012 Full Year

2011 Full Year

2010 Full Year

 
           

Merck

2013 Full Year (all reports available mid-page)

2012 Full Year

2011 Full Year

2010 Full Year

2009 Full Year

           

Pfizer

Q1

2012 Full Year

2011 Full Year

2010 Full Year

2009 Full Year

 

Q2

       
 

Q3

       
           

Sanofi Aventis

 

Q1

Q1

Q1

Q1

   

Q2

Q2

Q2

Q2

     

Q3

Q3

Q3

     

Q4

Q4

Q4

           

Shire

Q1

Q1

Q1

Q1

Q1

 

Q2

Q2

Q2

Q2

Q2

 

Q3

Q3

Q3

Q3

Q3

   

Q4

Q4

Q4

Q4

   

September 26, 2012

CME Grant Disclosure 2011 and 1st ½ of 2102

List


We have compiled a chart of companies that disclose their educational grant payments for  2011 and 2012.  Once the final Physician Payment Sunshine Act regulations are, it is likely that more companies will begin to post such payments to teaching hospitals in anticipation of
the rules to assist with implementation and compliance. It should be noted that many companies are posting rolling grants payments rather than cumulative grants payments. This means that current postings may not reflect historical transparency posting, but instead current year or last 4 quarters (2 common methods used).  So, for example, Janssen Pharmaceuticals has posted grants payments since 2010 but only current year Q1-Q2 (the most recent report) is available on our site.

Company

2012

2011

2010

2009

2008

Abbott

 

Q1

Q1

Q1

 
 

 

Q2

Q2

Q2

 
 

 

Q3

Q3

Q3

Q3

 

 

Q4

Q4

Q4

Q4

 

 

 

     

Allergan

Q1 & Q2

Q1 & Q2

     
 

 

Q3 & Q4

Q3

   
 

 

 

     

Amgen

Q1

Q1

Q1

Q1

Q1

 

Q2

Q2

Q2

Q2

Q2

 

 

Q3

Q3

Q3

Q3

 

 

Q4

Q4

Q4

Q4

 

 

 

     

Amilyn

Q1 & Q2

 2011

Q1

Q1

 
 

 

 

Q2

Q2

 
 

 

 

Q3

Q3

 
 

 

 

 

Q4

 
 

 

 

     

Amilyn Lilly Grant Office

 

 

Q1

Q1

 
 

 

 

Q2

Q2

 
 

 

 

Q3

Q3

 
 

 

 

 

Q4

 

Astellas Pharma US, Inc.

Q1

Q1

Q1

Q4

 
 

Q2

Q2

Q2

   
 

 

Q3

Q3

   
 

 

Q4

Q4

   
 

 

 

     

Astra Zeneca

Q1& Q2 2012

Q1 & Q2 2011

Q1 & Q2 2010

Q1 & Q2 2009

Q1 & Q2 2008

 

 

Q3 &Q4 2011

 Q3 &Q4 2010

 Q3 &Q4 2009

 Q3 &Q4 2008

 

 

 

     

Bristol-Myers Squibb

Q1

Q1

Q1

   
 

Q2

Q2

Q2

   
 

 

Q3

Q3

   
 

 

Q4

Q4

   
 

 

 

     

GlaxoSmithKline

Q1 & Q2 2012

Full Year

Full Year

Full Year

Full Year 2008

 

 

 

     

Genentech

 

Q1

Q1

   
 

 

Q2

Q2

   
 

 

 

Q3

   
 

 

 

Q4

   
 

 

 

     

Forest Labs

Q1

Full Year

Full Year

   

Johnson and Johnson Companies

 

 

     
 

 

 

     

Biosense Webster

Q1 2012; Q2-Q4 2011

 

     

Janssen Biotech

Q1 & Q2

Q1 & Q2 2011

     

Cordis

Q1 2012; Q2-Q4 2011

 

     

Depuy Mitek, Inc.

Q1 2012; Q2-Q4 2011

 

     

Depuy Orthopaedics, Inc.

Q1 2012; Q2-Q4 2011

Q1 2011 – Q1 2010

     

Depuy Spine, Inc.

Q1 2012; Q2-Q4 2011

Q1 2011 – Q2 2010

     

Codman and Shurtleff, Inc.

Q1 2012; Q2-Q4 2011

Q1 2011 – Q2 2010

     

Ethicon

Q1 2012; Q2-Q4 2011

Q1 2011 – Q2 2010

     

Ethicon Endo Surgery, Inc.

 

 

     

Janssen Pharmaceuticals, Inc.

Q2

 

     

Janessen Biotech, Inc.

 

Q1 2011

     

Janssen Therapeutics

Q2

 

     

Therakos

Q1 2012; Q2-Q4 2011

 

     

Eli Lilly

 

Full Year

Full Year

Full Year

 
 

 

 

     

Merck

Q1

Q1

Q1

Q1

Q3

 

Q2

Q2

Q2

Q2

Q4

 

 

Q3

Q3

Q3

 
 

 

Q4

Q4

Q4

 
 

 

 

     

Pfizer

Q1 &Q2

2011

2010

2009

2008

 

 

 

     

Sanofi Aventis

Q1

Q1

Q1

Q1

 
 

 

Q2

Q2

Q2

 
 

 

Q3

Q3

Q3

 
 

 

Q4

Q4

Q4

 
 

 

 

     

Shire

Q1

Q1

Q1

Q1

 
 

Q2

Q2

Q2

Q2

 
 

 

Q3

Q3

Q3

 
 

 

Q4

Q4

Q4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Newsletter


Preview | Powered by FeedBlitz

Search


 
Sponsors
May 2015
Sun Mon Tue Wed Thu Fri Sat
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31